Population pharmacokinetics/pharmacodynamics modeling: Parametric and nonparametric methods

被引：37
|
作者：
Jelliffe, R [1 ]
Schumitzky, A [1 ]
Van Guilder, M [1 ]
机构：
[1] Univ So Calif, Sch Med, Div Geriatr Med, Lab Appl Pharmacokinet, Los Angeles, CA 90033 USA
来源：
THERAPEUTIC DRUG MONITORING | 2000年 / 22卷 / 03期
关键词：
population pharmacokinetic modeling; pharmacodynamic modeling; parametric methods; nonparametric methods;
D O I：
10.1097/00007691-200006000-00019
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
As clinicians acquire experience with the clinical and pharmacokinetic behavior of a drug, it is usually optimal to record this experience in the form of a population pharmacokinetic model, and then to relate the behavior of the model to the clinical effects of the drug or to a linked pharmacodynamic model. The role of population modeling is thus to describe and record clinical experience with the behavior of a drug in a certain group or population of patients or subjects.
引用
收藏
页码：354 / 365
页数：12
相关论文
共 50 条
  • [41] Parametric Approaches in Population Pharmacokinetics
    Guidi, Monia
    Csajka, Chantal
    Buclin, Thierry
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (02): : 125 - 141
  • [42] Population Modeling and Monte Carlo Simulation Study of the Pharmacokinetics and Antituberculosis Pharmacodynamics of Rifampin in Lungs
    Goutelle, Sylvain
    Bourguignon, Laurent
    Maire, Pascal H.
    Van Guilder, Michael
    Conte, John E., Jr.
    Jelliffe, Roger W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (07) : 2974 - 2981
  • [43] A population pharmacokinetic model of trimethoprim in patients with pneumocystis pneumonia, made with parametric and nonparametric methods
    Jelliffe, RW
    Gomis, P
    Tahani, B
    Ruskin, J
    Sattler, FR
    THERAPEUTIC DRUG MONITORING, 1997, 19 (04) : 450 - 459
  • [44] Ethnic differences in the population pharmacokinetics and pharmacodynamics of warfarin
    Yuen, Eunice
    Gueorguieva, Ivelina
    Wise, Stephen
    Soon, Danny
    Aarons, Leon
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2010, 37 (01) : 3 - 24
  • [45] POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF OZANIMOD IN ULCERATIVE COLITIS
    Tatosian, Daniel
    Shen, Jun
    Chen, Lu
    Lavigne, Jean
    Teuscher, Nathan
    Harris, Sarah
    Chitkara, Denesh
    Tirucherai, Giridhar
    Marta, Cecilia
    INFLAMMATORY BOWEL DISEASES, 2022, 28 : S16 - S16
  • [46] Population pharmacokinetics and pharmacodynamics of biapenem in paediatric patients
    Ikawa, K.
    Morikawa, N.
    Ikeda, K.
    Miki, M.
    Nishimura, S.
    Kobayashi, M.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2008, 33 (02) : 203 - 210
  • [47] A POPULATION ANALYSIS OF THE PHARMACOKINETICS AND PHARMACODYNAMICS OF MIDAZOLAM IN THE RAT
    AARONS, L
    MANDEMA, JW
    DANHOF, M
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1991, 19 (05): : 485 - 496
  • [48] Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis
    Alghamdi, Wael A.
    Alsultan, Abdullah
    Al-Shaer, Mohammad H.
    An, Guohua
    Ahmed, Shahriar
    Alkabab, Yosra
    Banu, Sayera
    Barbakadze, Ketevan
    Houpt, Eric
    Kipiani, Maia
    Mikiashvili, Lali
    Schmidt, Stephan
    Heysell, Scott K.
    Kempker, Russell R.
    Cegielski, J. Peter
    Peloquin, Charles A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (05)
  • [49] Pharmacokinetics and pharmacodynamics of eptifibatide in healthy Chinese population
    Qiu, X. W.
    Xiang, R. F.
    Xiong, L. R.
    Yu, M. J.
    Chen, Y. Ch.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 127 : 6 - 6
  • [50] POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF OZANIMOD IN ULCERATIVE COLITIS
    Tatosian, Daniel
    Shen, Jun
    Chen, Lu
    Lavigne, Jean
    Teuscher, Nathan
    Harris, Sarah
    Chitkara, Denesh
    Tirucherai, Giridhar
    Marta, Cecilia
    GASTROENTEROLOGY, 2022, 162 (03) : S16 - S16
12345